Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus

Journal of Managed Care Pharmacy

Volumn 16, Issue 4, 2010, Pages 264-275

  Menzin, Joseph ^a   Korn, Jonathan R ^a   Cohen, Joseph ^b   Lobo, Francis ^c   Zhang, Bin ^a   Friedman, Mark ^a   Neumann, Peter J ^d  

^a Boston Health Economics Inc   (United States)

^b Fallon Clinic   (United States)

^c TAKEDA PHARMACEUTICALS   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BINOMIAL DISTRIBUTION; DEATH; ELECTROLYTE DISTURBANCE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL COST; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PNEUMONIA; POISSON DISTRIBUTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; STROKE; URINARY TRACT INFECTION;

EID: 77953310323     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2010.16.4.264     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention. Diabetes. Success and opportunities for population-based prevention and control: at a glance 2009. Available at: http://www.cdc.gov/nccdphp/publications/aag/ddt.htm. Accessed March 31, 2010.
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-87.
3. American Diabetes Association. Standards of medical care in diabetes - 2010. Diabetes Care. 2010;33(Suppl 1):S11-S61. Available at: http://care. diabetesjournals.org/content/33/Supplement-1/S11.full.pdf+html. Accessed March 31, 2010.
4. Centers for Disease Control and Prevention. National diabetes fact sheet, 2007. Available at: http://www.cdc.gov/diabetes/pubs/pdf/ndfs-2007.pdf. Accessed March 31, 2010.
5. Wagner EH, Sandhu N, Newton KM, McCulloch DK, Ramsey SD, Grothaus LC. Effect of improved glycemic control on health care costs and utilization. JAMA. 2001;285(2):182-89. Available at: http://jama.ama-assn. org/cgi/reprint/285/2/ 182. Accessed March 31, 2010.
6. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R. Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care. 2001;24(1):51-55. Available at: http://care.diabetesjournals.org/content/24/1/51.full.pdf+html. Accessed March 31, 2010. (Pubitemid 32104219)
7. Gilmer TP, O'Connor PJ, Rush WA et al. Predictors of health care costs in adults with diabetes. Diabetes Care. 2005;28(1):59-64. Available at: http:// care.diabetesjournals.org/content/28/1/59.full.pdf+html. Accessed March 31, 2010.
8. Shetty S, Secnik K, Oglesby AK. Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes. J Manag Care Pharm. 2005;11(7):559-64. Available at: http://www. amcp.org/data/jmcp/Original%20Research-559-564.pdf.
9. Oglesby AK, Secnik K, Barron J, Al-Zakwani I, Lage MJ. The association between diabetes-related medical costs and glycemic control: a retrospective analysis. Cost Eff Resour Alloc. 2006;4:1. Available at: http://www.ncbi.nlm. nih.gov/pmc/articles/PMC1369002/pdf/1478-7547-4-1.pdf. Accessed March 31, 2010.
10. U.S. Department of Health and Human Services. Agency for Healthcare Research and Quality (AHRQ), Healthcare Cost and Utilization Project (HCUP). Available at: www.ahrq.gov/data/hcup. Accessed March 31, 2010.
11. Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. R-2754-HHS. The Rand Corporation. January 1982. Available at: http://www.rand.org/pubs/ reports/2006/R2754.pdf. Accessed March 31, 2010.
12. Kelly TN, Bazzano LA, Fonseca VA, Thethi TK, Reynolds K, He J. Systematic review: glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med. 2009;151(6):394-403. Available at: http://www. annals.org/content/ 151/6/394.full.pdf+html. Accessed March 31, 2010.
13. Montori VM, Fernandez-Balsells M. Glycemic control in type 2 diabetes: time for an evidence-based about-face? Ann Intern Med. 2009;150(11):803-08. Available at: http://www.annals.org/content/150/11/803.full.pdf+html. Accessed March 31, 2010.
14. Skyler JS, Bergenstal R, Bonow RO, et al. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care. 2009;32(1):187-92. Available at: http://care.diabetesjournals.org/content/ 32/1/187.full.pdf+html. Accessed March 31, 2010.
15. Ray KK, Seshasai SR, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373(9677):1765- 72.
16. Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-53. Available at: http://content.nejm.org/cgi/ reprint/353/25/2643.pdf. Accessed March 31, 2010.
17. American Medical Association. AMA Hospital ICD-9-CM 2009 Vols 1, 2, and 3. Chicago, IL: American Medical Association Press; 2008.
18. Bright RA, Avorn J, Everitt DE. Medicaid data as a resource for epidemiologic studies: strengths and limitations. J Clin Epidemiol. 1989;42(10):937-45. (Pubitemid 19269618)
19. Iezzoni LI. Assessing quality using administrative data. Ann Intern Med. 1997;127(8 Pt 2):666-74. Available at: http://annals.org/content/127/8-Part-2/ 666.full.pdf+html. Accessed January 18, 2010.